This special issue represents an attempt to answer fundamental brain a
nd behaviour issues in attention-deficit hyperactivity disorder (ADHD)
. The European network on hyperkinetic disorders (Eunethydis) is tryin
g to develop a novel, testable theory of ADHD, giving an account of it
s causes, its development from brain dysfunctions to behavioural sympt
oms and co-morbidity and explaining why no current therapy produces lo
ng-lasting improvements. The combined insights of the articles present
ed here suggest that there is no brain damage in ADHD, but hypo-effici
ent dopamine systems which give rise to neurochemical imbalances. Thes
e cause behavioural problems: deficits in sustained attention, overact
ivity and impulsiveness. Impulsiveness is increasingly being seen as a
key characteristic of the disorder. None of these symptoms are necess
arily primary, but may be secondary to an underlying deficit in reinfo
rcement processes seen particularly in a greater than normal sensitivi
ty to variations in the timing of stimulus presentation. Other symptom
s can also be seen: altered effects of reinforcers, increased behaviou
ral variance and motor co-ordination problems. Medication produces tem
porary, plastic changes in cellular components like receptors and tran
sduction mechanisms normalising dopamine functions and behaviour. (C)
1998 Elsevier Science B.V. All rights reserved.